4-[(5,11-dimethyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]-N-[4-[[2-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxy]acetyl]amino]butyl]-3-methoxybenzamide

C40H41N9O8 — CID 167028016

IUPAC4-[(5,11-dimethyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]-N-[4-[[2-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxy]acetyl]amino]butyl]-3-methoxybenzamide
SMILESCOc1cc(C(=O)NCCCCNC(=O)COc2cccc3c2CN(C2CCC(=O)NC2=O)C3=O)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C
InChIInChI=1S/C40H41N9O8/c1-47-28-11-5-4-9-25(28)38(54)48(2)30-20-43-40(46-35(30)47)44-27-14-13-23(19-32(27)56-3)36(52)42-18-7-6-17-41-34(51)22-57-31-12-8-10-24-26(31)21-49(39(24)55)29-15-16-33(50)45-37(29)53/h4-5,8-14,19-20,29H,6-7,15-18,21-22H2,1-3H3,(H,41,51)(H,42,52)(H,43,44,46)(H,45,50,53)
InChIKeyDZBJWVRPMCZVOO-UHFFFAOYSA-N
MW775.82 g/mol
LogP3.05
Rot. Bonds13

About 4-[(5,11-dimethyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]-N-[4-[[2-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxy]acetyl]amino]butyl]-3-methoxybenzamide

4-[(5,11-dimethyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]-N-[4-[[2-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxy]acetyl]amino]butyl]-3-methoxybenzamide (PubChem CID 167028016) has the molecular formula C40H41N9O8 and a molecular weight of 775.82 g/mol. Its IUPAC name is 4-[(5,11-dimethyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]-N-[4-[[2-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxy]acetyl]amino]butyl]-3-methoxybenzamide.

Molecular Properties

Compound Name4-[(5,11-dimethyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]-N-[4-[[2-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxy]acetyl]amino]butyl]-3-methoxybenzamide
PubChem CID167028016
Molecular FormulaC40H41N9O8
Molecular Weight775.82 g/mol
Exact Mass775.31
IUPAC Name4-[(5,11-dimethyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]-N-[4-[[2-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxy]acetyl]amino]butyl]-3-methoxybenzamide
SMILESCOc1cc(C(=O)NCCCCNC(=O)COc2cccc3c2CN(C2CCC(=O)NC2=O)C3=O)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C
InChIInChI=1S/C40H41N9O8/c1-47-28-11-5-4-9-25(28)38(54)48(2)30-20-43-40(46-35(30)47)44-27-14-13-23(19-32(27)56-3)36(52)42-18-7-6-17-41-34(51)22-57-31-12-8-10-24-26(31)21-49(39(24)55)29-15-16-33(50)45-37(29)53/h4-5,8-14,19-20,29H,6-7,15-18,21-22H2,1-3H3,(H,41,51)(H,42,52)(H,43,44,46)(H,45,50,53)
InChIKeyDZBJWVRPMCZVOO-UHFFFAOYSA-N
XLogP3.05
TPSA204.50 Ų
H-Bond Donors4
H-Bond Acceptors12
Rotatable Bonds13
Heavy Atoms57
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500775.82
LogP ≤ 53.05
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 4-[(5,11-dimethyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]-N-[4-[[2-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxy]acetyl]amino]butyl]-3-methoxybenzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[(5,11-dimethyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]-N-[4-[[2-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxy]acetyl]amino]butyl]-3-methoxybenzamide?
The IUPAC name of 4-[(5,11-dimethyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]-N-[4-[[2-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxy]acetyl]amino]butyl]-3-methoxybenzamide (CID 167028016) is 4-[(5,11-dimethyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]-N-[4-[[2-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxy]acetyl]amino]butyl]-3-methoxybenzamide.
What is the SMILES notation for 4-[(5,11-dimethyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]-N-[4-[[2-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxy]acetyl]amino]butyl]-3-methoxybenzamide?
The canonical SMILES for 4-[(5,11-dimethyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]-N-[4-[[2-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxy]acetyl]amino]butyl]-3-methoxybenzamide is COc1cc(C(=O)NCCCCNC(=O)COc2cccc3c2CN(C2CCC(=O)NC2=O)C3=O)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C.
What is the InChIKey of 4-[(5,11-dimethyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]-N-[4-[[2-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxy]acetyl]amino]butyl]-3-methoxybenzamide?
The InChIKey is DZBJWVRPMCZVOO-UHFFFAOYSA-N. The full InChI is InChI=1S/C40H41N9O8/c1-47-28-11-5-4-9-25(28)38(54)48(2)30-20-43-40(46-35(30)47)44-27-14-13-23(19-32(27)56-3)36(52)42-18-7-6-17-41-34(51)22-57-31-12-8-10-24-26(31)21-49(39(24)55)29-15-16-33(50)45-37(29)53/h4-5,8-14,19-20,29H,6-7,15-18,21-22H2,1-3H3,(H,41,51)(H,42,52)(H,43,44,46)(H,45,50,53).
What are the key properties of 4-[(5,11-dimethyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]-N-[4-[[2-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxy]acetyl]amino]butyl]-3-methoxybenzamide?
4-[(5,11-dimethyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]-N-[4-[[2-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxy]acetyl]amino]butyl]-3-methoxybenzamide has a molecular weight of 775.82 g/mol, XLogP of 3.05, 13 rotatable bonds, 4 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(5,11-dimethyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]-N-[4-[[2-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]oxy]acetyl]amino]butyl]-3-methoxybenzamide is sourced from PubChem (CID 167028016), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).